ONCOLOGY INSTITUTE INC/THE

Insider RSU grants at Oncology Institute Inc. signal confidence ahead of Q2 earnings – may boost the stock’s upside.

Oncology Institute insiders trade sharply—C.M.O. Podnos Yale buys low, sells high to manage liquidity, not confidence. Learn the implications for investors.

Oncology Institute insider buying spikes: director Chernett Jorey’s latest 15,000‑share purchase signals confidence in value‑based care growth and a potential undervalued upside for long‑term investors.

Insider buying at Oncology Institute Inc. shows new bullish confidence—17,185 shares, no cash, and a strong balance sheet—hinting at future upside in oncology services.

Insider buying of Oncology Institute stock rises as Jorey’s incremental purchases signal confidence amid a 14.6% monthly gain and 134.8% YTD surge.

Insider sales and buys at Oncology Institute reveal mixed sentiment—does the recent sell signal confidence drops or just a planned exit? Discover the implications.

Insider buy of 12k shares at $4.75 shows The Oncology Institute’s strong growth momentum and investor confidence in its value‑based oncology services.